Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A Multicyclic Catalytic Network Enabling ROS Amplification, Metabolic Disruption, and Immune Modulation for Antitumor-Antibacterial Therapy.

Created on 13 Nov 2026

Authors

Chao Ban, Hailing Lin, Mingxin Cheng, Shuanglong Chen, Ziteng Hao, Yun Shen, Yubin Sha, Yangyin Xue, Jinkang Feng, Jiaxuan Chen, Weiwei Guo, Wancai Que

Published in

ACS applied materials & interfaces. Nov 12, 2026. Epub Nov 12, 2026.

Abstract

Intratumoral bacteria are increasingly recognized as important regulators of tumor progression, immune suppression, and metastasis, whereas current therapeutic strategies remain insufficient to address the coupled tumor-bacteria microenvironment. Here, we report a multicyclic catalytic network (VBC-Net) that integrates alkaline polyoxovanadate with a Bi2WO6-CuSx p-n heterojunction for coordinated antitumor-antibacterial immunotherapy. Unlike conventional single-mechanism nanozymes, VBC-Net establishes interconnected catalytic cycles that sustain ROS amplification, oxygen activation, and glutathione depletion, thereby converting transient catalytic activity into persistent oxidative stress. Simultaneously, the alkaline microenvironment and Bi-associated interference with respiratory-chain-related processes may contribute to metabolic perturbation, coupling oxidative stress with metabolic disruption. VBC-Net is further associated with dendritic-cell maturation, enhanced T-cell infiltration, and pro-inflammatory immune modulation, suggesting remodeling of the tumor-bacteria-immune microenvironment. In murine 4T1 tumor and MRSA-infected models, VBC-Net achieves pronounced tumor suppression, bacterial clearance, reduced metastatic progression, and accelerated wound healing with good biocompatibility. This work establishes a multicyclic catalytic strategy for targeting complex tumor-associated ecosystems and provides a promising framework for antitumor-antibacterial therapy.

PMID:
43019011
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement